Literature DB >> 30941436

Genotypic evolution and epidemiological characteristics of H9N2 influenza virus in Shandong Province, China.

Yue Li1, Mengda Liu1, Qinqin Sun1, Huixia Zhang1, Hui Zhang1, Shengnan Jiang1, Sidang Liu1, Yanyan Huang2.   

Abstract

H9N2 avian influenza has been prevalent in chicken flocks of China for years. In the first half year of 2018, clinical cases of suspected H9N2 infection were collected from chicken flocks in Shandong province. Nine strains of H9N2 influenza virus were isolated. The pathological changes of the dead chickens were mainly respiratory inflammation, renal swelling, and secondary infection. The microscopic lesions were consistent with the pathogenic characteristics of H9N2 influenza virus. From November 2017 to June 2018, a total of 3,380 serum samples were randomly collected from commercial laying hens in Shandong Province. The H9 antibody levels were tested with the isolated strain (CK/SD/231/17) as the antigen. It showed that the average of antibody titers of H9 avian influenza was 9.24 1og2. Hemagglutination inhibition experiments were conducted on chicken serum with the vaccine virus and the isolated virus (CK/SD/231/17) as the antigens. It was found that the antibody titer measured with the vaccine virus was 1 or 2 titers higher than the isolated strain. It indicated that the antigenicity of H9N2 circulating strain was different from that of vaccine strain. The nucleotide sequences of HA gene of these recent H9N2 avian influenza virus isolates shared homologies from 93.8 to 99.9%. Phylogenetic analysis revealed that the eight gene segments of the viruses were in the same clades with G57 gene reference strain. The amino acid site analysis of influenza resistance showed that the virus was sensitive to neuraminidase inhibitors and resistant to amantadine. Highlights: The protection rate of the H9N2 AIV vaccine almost reached 100% before 2016, but the antibody level of serum samples showed high diversity in this study, which means the poultry were infected. The antigenicity of isolated H9N2 strains was different from that of vaccine strain. Current available vaccines may provide only limited protection.
© 2019 Poultry Science Association Inc.

Entities:  

Keywords:  CK/GD/SS/94; CK/SH/F/98; H9N2 subtype; Shandong; avian influenza

Mesh:

Substances:

Year:  2019        PMID: 30941436     DOI: 10.3382/ps/pez151

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  7 in total

1.  Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.

Authors:  Xiaohong Xu; Jing Qian; Lingsong Qin; Jindou Li; Cong Xue; Jiaxin Ding; Weiqi Wang; Wei Ding; Renfu Yin; Ningyi Jin; Zhuang Ding
Journal:  Virol Sin       Date:  2020-04-09       Impact factor: 4.327

2.  HA gene amino acid mutations contribute to antigenic variation and immune escape of H9N2 influenza virus.

Authors:  Rui Zhu; Shunshun Xu; Wangyangji Sun; Quan Li; Shifeng Wang; Huoying Shi; Xiufan Liu
Journal:  Vet Res       Date:  2022-06-15       Impact factor: 3.829

3.  The molecular evolutionary characteristics of new isolated H9N2 AIV from East China and the function of vimentin on virus replication in MDCK cells.

Authors:  Yuan Nan Yu; Yang Zheng; Shan Shan Hao; Ze Zhang; Jia Xi Cai; Man Man Zong; Xiu Li Feng; Qing Tao Liu
Journal:  Virol J       Date:  2020-06-17       Impact factor: 4.099

4.  Comparative analysis of key immune protection factors in H9N2 avian influenza viruses infected and immunized specific pathogen-free chicken.

Authors:  Manman Dai; Shibing Li; Hui Sun; Li Zhao; Jiayu Liao; Chenggang Xu; Ming Liao
Journal:  Poult Sci       Date:  2020-10-09       Impact factor: 3.352

5.  Genetic Evolution of Avian Influenza A (H9N2) Viruses Isolated from Domestic Poultry in Uganda Reveals Evidence of Mammalian Host Adaptation, Increased Virulence and Reduced Sensitivity to Baloxavir.

Authors:  Gladys Atim; Titus Tugume; Qouilazoni A Ukuli; Bernard Erima; Andrew Mubiru; Hannah Kibuuka; Edison Mworozi; Pamela McKenzie; Jasmine C M Turner; David Walker; Trushar Jeevan; Robert G Webster; Jeremy Jones; Richard J Webby; Mariette F Ducatez; Fred Wabwire-Mangen; Denis K Byarugaba
Journal:  Viruses       Date:  2022-09-18       Impact factor: 5.818

6.  Avian Influenza A Viruses among Occupationally Exposed Populations, China, 2014-2016.

Authors:  Chuansong Quan; Qianli Wang; Jie Zhang; Min Zhao; Qigang Dai; Ting Huang; Zewu Zhang; Shenghua Mao; Yifei Nie; Jun Liu; Yun Xie; Baorong Zhang; Yuhai Bi; Weifeng Shi; Peipei Liu; Dayan Wang; Luzhao Feng; Hongjie Yu; William J Liu; George F Gao
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

7.  Assessing the efficacy of a recombinant H9N2 avian influenza virus-inactivated vaccine.

Authors:  Cai Liang Song; Zhi Hong Liao; Yong Shen; Huang Wang; Wen Cheng Lin; Hongxin Li; Wei Guo Chen; Qing Mei Xie
Journal:  Poult Sci       Date:  2020-06-24       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.